COPD Overdiagnosis and Its Effect on 30-Day Hospital Readmission Rates

References

1. 1.↵
   1. Sullivan J,
   2. Pravosud V,
   3. Mannino DM,
   4. Siegel K,
   5. Choate R,
   6. Sullivan T

   . National and state estimates of COPD morbidity and mortality- United States, 2014–2015. Chronic Obstr Pulm Dis 2018;5(4):324–333.

   OpenUrlCrossRef
2. 2.
   1. Gershon AS,
   2. Warner L,
   3. Cascagnette P,
   4. Victor JC,
   5. To T

   . Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet 2011;378(9795):991–996.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Buist AS,
   2. McBurnie MA,
   3. Vollmer WM,
   4. Gillespie S,
   5. Burney P,
   6. Mannino DM,
   7. et al

   . International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet 2007;370(9589):741–750.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Ford ES,
   2. Murphy LB,
   3. Khavjou O,
   4. Giles WH,
   5. Holt JB,
   6. Croft JB

   . Total and state-specific medial and absenteesim costs of COPD among adults aged greater than 18 years in the United States for 2010 and projections through 2020. Chest 2015;147(1):31–45.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Shah T,
   2. Press V,
   3. Huisingh-Scheetz M,
   4. White SR

   . COPD readmissions: addressing COPD in the era of value-based health care. Chest 2016;150(4):916–926.

   OpenUrl
6. 6.↵
   1. Almagro P,
   2. Calbo E,
   3. Ochoa de Echagüen A,
   4. Barreiro B,
   5. Quintana S,
   6. Heredia JL,
   7. Garau J

   . Mortality after hospitalization for COPD. Chest 2002;121(5):1441–1448.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. McIlvennan CK,
   2. Eapen ZJ,
   3. Allen LA

   . Hospital readmissions reduction program. Circ J 2015;131(20):1796–1803.

   OpenUrl
8. 8.↵
   Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of chronic obstructive pulmonary disease: 2019 Report. Available at: http://www.goldcopd.org. Accessed June 3, 2020.
9. 9.↵
   1. Hangaard S,
   2. Helle T,
   3. Nielsen C,
   4. Hejlesen OK

   . Causes of misdiagnosis of chronic obstructive pulmonary disease: a systematic scoping review. Respir Med 2017;129:63–84.

   OpenUrl
10. 10.↵
    1. Gershon AS,
    2. Hwee J,
    3. Chapman KR,
    4. Aaron SD,
    5. O'Donnell DE,
    6. Stanbrook MB,
    7. et al

    . Factors associated with undiagnosed and overdiagnosed COPD. Eur Respir J 2016;48(2):561–564.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Chapman KR,
    2. Tashkin DP,
    3. Pye DJ

    . Gender bias in the diagnosis of COPD. Chest 2001;119(6):1691–1695.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Jain VV,
    2. Allison DR,
    3. Andrews S,
    4. Mejia J,
    5. Mills PK,
    6. Peterson MW

    . Misdiagnosis among frequent exacerbators of clinically diagnosed asthma and COPD in absence of confirmation of airflow obstruction. Lung 2015;193(4):505–512.

    OpenUrl
13. 13.
    1. Bourbeau J,
    2. O'Donnell D,
    3. Maltais F,
    4. Marciniuk D,
    5. Benedetti A,
    6. Aaron S

    . What are the factors related to misdiagnosis of COPD? Eur Respir J 2014;38(Suppl 55):p261.

    OpenUrl
14. 14.↵
    1. Spero K,
    2. Bayasi G,
    3. Beaudry L,
    4. Barber KR,
    5. Khorfan F

    . Overdiagnosis of COPD in hospitalized patients. Int J Chron Obstruct Pulmon Dis 2017;12:2417–2423.

    OpenUrl
15. 15.↵
    1. Lamprecht B,
    2. Mahringer A,
    3. Soriano J,
    4. Kaiser B,
    5. Buist AS,
    6. Studnicka M

    . Is spirometry properly used to diagnose COPD? Results from the BOLD study in Salzburg, Austria: a population-based analytical study. Prim Care Respir J 2013;22(2):195–200.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Nardini S,
    2. Annesi-Maesano I,
    3. Simoni M,
    4. del Ponte A,
    5. Sanguinetti CM,
    6. De Benedetto F

    . Accuracy of diagnosis of COPD and factors associated with misdiagnosis in primary care setting. E-DIAL (Early DIAgnosis of obstructive lung disease) study group. Respir Med 2018;143:61–66.

    OpenUrl
17. 17.↵
    1. Sator L,
    2. Horner A,
    3. Studnicka M,
    4. Lamprecht B,
    5. Kaiser B,
    6. McBurnie MA,
    7. et al

    . Overdiagnosis of COPD in subjects with unobstructed spirometry: a BOLD analysis. Chest 2019;156(2):277–288.

    OpenUrl
18. 18.↵
    1. Miller MR,
    2. Levy ML

    . Chronic obstructive pulmonary disease: missed diagnosis versus misdiagnosis. BMJ 2015;351:h3021.

    OpenUrlFREE Full Text
19. 19.↵
    1. Russo AN,
    2. Sathiyamoorthy G,
    3. Lau C,
    4. Saygin D,
    5. Han X,
    6. Wang X-F,
    7. et al

    . Impact of a post-discharge integrated disease management program on COPD hospital readmissions. Respir Care 2017;62(11):1396–1402.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Ruppel GL,
    2. Carlin BW,
    3. Hart M,
    4. Doherty DE

    . Office spirometry in primary care for the diagnosis and management of COPD: national lung health education program update. Respir Care 2018;63(2):242–252.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Swanney MP,
    2. Ruppel G,
    3. Enright PL,
    4. Pedersen OF,
    5. Crapo RO,
    6. Miller MR,
    7. et al

    . Using the lower limit of normal for the FEV₁/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008;63(12):1046–1051.

    OpenUrlAbstract/FREE Full Text
22. 22.
    1. Miller MR,
    2. Quanjer PH,
    3. Swanney MP,
    4. Ruppel G,
    5. Enright PL

    . Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. Chest 2011;139(1):52–59.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Culver BH

    . How should the lower limit of normal range be defined? Respir Care 2012;57(1):136–145.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Arne M,
    2. Lisspers K,
    3. Ställberg B,
    4. Boman G,
    5. Hedenström H,
    6. Janson C,
    7. Emtner M

    . How often is diagnosis of COPD confirmed with spirometry? Respir Med 2010;104(4):550–556.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Woodruff PG,
    2. Barr RG,
    3. Bleecker E,
    4. Christenson SA,
    5. Couper D,
    6. Curtis JL,
    7. et al

    . Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med 2016;374(19):1811–1821.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Hawkins NM,
    2. Petrie MC,
    3. Jhund PS,
    4. Chalmers GW,
    5. Dunn FG,
    6. McMurray J

    . Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 2009;11(2):130–139.

    OpenUrlCrossRefPubMed